EMEA All Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2022

September 2017 | 122 pages | ID: E3A206E5EEFEN
GlobalInfoResearch

Abstracts

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or 'wild' pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).

SCOPE OF THE REPORT:

This report focuses on the All Vaccine in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

• CNBG
• ChengDa Bio
• Changsheng Life
• Zhifei
• SINOVAC BIOTECH
• NuoCheng Bio
• Hualan Bio
• Kangtai
• SANOFI PASTEUR S.A.
• Novartis
• GSK

Market Segment by Regions, regional analysis covers

• Europe (Germany, France, UK, Russia, Italy and Turkey)
• Middle East (Saudi Arabia, Israel, UAE and Iran)
• Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers

• Varicella
• Influenza
• Polio
• Hepatitis A
• Rabies
• BCG
• Hepatitis B
• Pertussis, Diphtheria, tetanus
• Pneumococcal
• Other

Market Segment by Applications, can be divided into

• For Adult
• For Child

There are 13 Chapters to deeply display the EMEA All Vaccine market.

Chapter 1, to describe All Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of All Vaccine, with sales, revenue, and price of All Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of All Vaccine, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, All Vaccine market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe All Vaccine research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 All Vaccine Introduction
1.2 Market Analysis by Type
  1.2.1 Varicella
  1.2.2 Influenza
  1.2.3 Polio
  1.2.4 Hepatitis A
  1.2.5 Rabies
  1.2.6 BCG
  1.2.7 Hepatitis B
  1.2.8 Pertussis, Diphtheria, tetanus
  1.2.9 Pneumococcal
  1.2.10 Other
1.3 Market Analysis by Applications
  1.3.1 For Adult
  1.3.2 For Child
1.4 Market Analysis by Regions
  1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
    1.4.1.1 Germany Market States and Outlook (2012-2022)
    1.4.1.2 France Market States and Outlook (2012-2022)
    1.4.1.3 UK Market States and Outlook (2012-2022)
    1.4.1.4 Italy Market States and Outlook (2012-2022)
    1.4.1.5 Russia Market States and Outlook (2012-2022)
    1.4.1.6 Turkey Market States and Outlook (2012-2022)
  1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
    1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.2.2 UAE Market States and Outlook (2012-2022)
    1.4.2.3 Israel Market States and Outlook (2012-2022)
    1.4.2.4 Iran Market States and Outlook (2012-2022)
  1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
    1.4.3.1 South Africa Market States and Outlook (2012-2022)
    1.4.3.2 Nigeria Market States and Outlook (2012-2022)
    1.4.3.3 Egypt Market States and Outlook (2012-2022)
    1.4.3.4 Algeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 CNBG
  2.1.1 Business Overview
  2.1.2 All Vaccine Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 CNBG All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 ChengDa Bio
  2.2.1 Business Overview
  2.2.2 All Vaccine Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 ChengDa Bio All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Changsheng Life
  2.3.1 Business Overview
  2.3.2 All Vaccine Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Changsheng Life All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Zhifei
  2.4.1 Business Overview
  2.4.2 All Vaccine Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Zhifei All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 SINOVAC BIOTECH
  2.5.1 Business Overview
  2.5.2 All Vaccine Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 SINOVAC BIOTECH All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 NuoCheng Bio
  2.6.1 Business Overview
  2.6.2 All Vaccine Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 NuoCheng Bio All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hualan Bio
  2.7.1 Business Overview
  2.7.2 All Vaccine Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Hualan Bio All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Kangtai
  2.8.1 Business Overview
  2.8.2 All Vaccine Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Kangtai All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 SANOFI PASTEUR S.A.
  2.9.1 Business Overview
  2.9.2 All Vaccine Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 SANOFI PASTEUR S.A. All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Novartis
  2.10.1 Business Overview
  2.10.2 All Vaccine Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 Novartis All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 GSK
  2.11.1 Business Overview
  2.11.2 All Vaccine Type and Applications
    2.11.2.1 Type
    2.11.2.2 Type
  2.11.3 GSK All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 EMEA ALL VACCINE MARKET COMPETITION, BY MANUFACTURER

3.1 EMEA All Vaccine Sales and Market Share by Manufacturer
3.2 EMEA All Vaccine Revenue and Market Share by Manufacturer
3.3 EMEA All Vaccine Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 All Vaccine Manufacturer Market Share
  3.4.2 Top 5 All Vaccine Manufacturer Market Share
3.5 Market Competition Trend

4 EMEA ALL VACCINE MARKET ANALYSIS BY REGIONS

4.1 EMEA All Vaccine Sales, Revenue and Market Share by Regions
  4.1.1 EMEA All Vaccine Sales by Regions (2012-2017)
  4.1.2 EMEA All Vaccine Revenue by Regions (2012-2017)
4.2 Europe All Vaccine Sales and Growth (2012-2017)
4.3 Middle East All Vaccine Sales and Growth (2012-2017)
4.4 Africa All Vaccine Sales and Growth (2012-2017)

5 EUROPE ALL VACCINE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 Europe All Vaccine Sales, Revenue and Market Share by Countries
  5.1.1 Europe All Vaccine Sales by Countries (2012-2017)
  5.1.2 Europe All Vaccine Revenue by Countries (2012-2017)
  5.1.3 Germany All Vaccine Sales and Growth (2012-2017)
  5.1.4 France All Vaccine Sales and Growth (2012-2017)
  5.1.5 UK All Vaccine Sales and Growth (2012-2017)
  5.1.6 Russia All Vaccine Sales and Growth (2012-2017)
  5.1.7 Italy All Vaccine Sales and Growth (2012-2017)
  5.1.8 Turkey All Vaccine Sales and Growth (2012-2017)
5.2 Europe All Vaccine Sales and Revenue (value) by Manufacturers (2016-2017)
  5.2.1 Europe All Vaccine Sales by Manufacturers (2016-2017)
  5.2.2 Europe All Vaccine Revenue by Manufacturers (2016-2017)
5.3 Europe All Vaccine Sales by Type (2012-2017)
5.4 Europe All Vaccine Sales by Application (2012-2017)

6 MIDDLE EAST ALL VACCINE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Middle East All Vaccine Sales, Revenue and Market Share by Countries
  6.1.1 Middle East All Vaccine Sales by Countries (2012-2017)
  6.1.2 Middle East All Vaccine Revenue by Countries (2012-2017)
  6.1.3 Saudi Arabia All Vaccine Sales and Growth (2012-2017)
  6.1.4 Israel All Vaccine Sales and Growth (2012-2017)
  6.1.5 UAE All Vaccine Sales and Growth (2012-2017)
  6.1.6 Iran All Vaccine Sales and Growth (2012-2017)
6.2 Middle East All Vaccine Sales and Revenue (value) by Manufacturers (2016-2017)
  6.2.1 Middle East All Vaccine Sales by Manufacturers (2016-2017)
  6.2.2 Middle East All Vaccine Revenue by Manufacturers (2016-2017)
6.3 Middle East All Vaccine Sales by Type (2012-2017)
6.4 Middle East All Vaccine Sales by Application (2012-2017)

7 AFRICA ALL VACCINE BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Africa All Vaccine Sales, Revenue and Market Share by Countries
  7.1.1 Africa All Vaccine Sales by Countries (2012-2017)
  7.1.2 Africa All Vaccine Revenue by Countries (2012-2017)
  7.1.3 South Africa All Vaccine Sales and Growth (2012-2017)
  7.1.4 Nigeria All Vaccine Sales and Growth (2012-2017)
  7.1.5 Egypt All Vaccine Sales and Growth (2012-2017)
  7.1.6 Algeria All Vaccine Sales and Growth (2012-2017)
7.2 Middle East All Vaccine Sales and Revenue (value) by Manufacturers (2016-2017)
  7.2.1 Middle East All Vaccine Sales by Manufacturers (2016-2017)
  7.2.2 Middle East All Vaccine Revenue by Manufacturers (2016-2017)
7.3 Middle East All Vaccine Sales by Type (2012-2017)
7.4 Middle East All Vaccine Sales by Application (2012-2017)

8 EMEA ALL VACCINE MARKET SEGMENT BY TYPE

8.1 EMEA All Vaccine Sales, Revenue and Market Share by Type (2012-2017)
  8.1.1 EMEA All Vaccine Sales and Market Share by Type (2012-2017)
  8.1.2 EMEA All Vaccine Revenue and Market Share by Type (2012-2017)
8.2 Varicella Sales Growth and Price
  10.2.1 EMEA Varicella Sales Growth (2012-2017)
  10.2.2 EMEA Varicella Price (2012-2017)
8.3 Influenza Sales Growth and Price
  10.3.1 EMEA Influenza Sales Growth (2012-2017)
  10.3.2 EMEA Influenza Price (2012-2017)
8.4 Polio Sales Growth and Price
  10.4.1 EMEA Polio Sales Growth (2012-2017)
  10.4.2 EMEA Polio Price (2012-2017)
8.5 Hepatitis A Sales Growth and Price
  10.5.1 EMEA Hepatitis A Sales Growth (2012-2017)
  10.5.2 EMEA Hepatitis A Price (2012-2017)
8.6 Rabies Sales Growth and Price
  10.6.1 EMEA Rabies Sales Growth (2012-2017)
  10.6.2 EMEA Rabies Price (2012-2017)
8.7 BCG Sales Growth and Price
  10.7.1 EMEA BCG Sales Growth (2012-2017)
  10.7.2 EMEA BCG Price (2012-2017)
8.8 Hepatitis B Sales Growth and Price
  10.8.1 EMEA Hepatitis B Sales Growth (2012-2017)
  10.8.2 EMEA Hepatitis B Price (2012-2017)
8.9 Pertussis, Diphtheria, tetanus Sales Growth and Price
  10.9.1 EMEA Pertussis, Diphtheria, tetanus Sales Growth (2012-2017)
  10.9.2 EMEA Pertussis, Diphtheria, tetanus Price (2012-2017)
8.10 Pneumococcal Sales Growth and Price
  10.10.1 EMEA Pneumococcal Sales Growth (2012-2017)
  10.10.2 EMEA Pneumococcal Price (2012-2017)
8.11 Other Sales Growth and Price
  8.11.1 EMEA Other Sales Growth (2012-2017)
  8.11.2 EMEA Other Price (2012-2017)

9 EMEA ALL VACCINE MARKET SEGMENT BY APPLICATION

9.1 EMEA All Vaccine Sales Market Share by Application (2012-2017)
9.2 For Adult Sales Growth (2012-2017)
9.3 For Child Sales Growth (2012-2017)

10 EMEA ALL VACCINE MARKET FORECAST (2017-2022)

10.1 EMEA All Vaccine Sales, Revenue and Growth Rate (2017-2022)
10.2 All Vaccine Market Forecast by Regions (2017-2022)
  10.2.1 Europe All Vaccine Market Forecast by Regions (2017-2022)
    10.2.1.1 Germany All Vaccine Sales Forecast 2017-2022
    10.2.1.2 France All Vaccine Sales Forecast 2017-2022
    10.2.1.3 UK All Vaccine Sales Forecast 2017-2022
    10.2.1.4 Russia All Vaccine Sales Forecast 2017-2022
    10.2.1.5 Italy All Vaccine Sales Forecast 2017-2022
    10.2.1.6 Turkey All Vaccine Sales Forecast 2017-2022
  10.2.2 Middle East Market Forecast by Regions (2017-2022)
    10.2.2.1 Saudi Arabia All Vaccine Sales Forecast 2017-2022
    10.2.2.2 Israel All Vaccine Sales Forecast 2017-2022
    10.2.2.3 UAE All Vaccine Sales Forecast 2017-2022
    10.2.2.4 Iran All Vaccine Sales Forecast 2017-2022
  10.2.3 Africa Market Forecast by Regions (2017-2022)
    10.2.3.1 South Africa All Vaccine Sales Forecast 2017-2022
    10.2.3.2 Nigeria All Vaccine Sales Forecast 2017-2022
    10.2.3.3 Egypt All Vaccine Sales Forecast 2017-2022
    10.2.3.4 Algeria All Vaccine Sales Forecast 2017-2022
10.3 All Vaccine Market Forecast by Type (2017-2022)
10.4 All Vaccine Market Forecast by Application (2017-2022)

11 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

11.1 Sales Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Future Trend
11.2 Distributors, Traders and Dealers

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure All Vaccine Picture
Table Product Specifications of All Vaccine
Figure EMEA Sales Market Share of All Vaccine by Types in 2016
Table All Vaccine Types for Major Manufacturers
Figure Varicella Picture
Figure Influenza Picture
Figure Polio Picture
Figure Hepatitis A Picture
Figure Rabies Picture
Figure BCG Picture
Figure Hepatitis B Picture
Figure Pertussis, Diphtheria, tetanus Picture
Figure Pneumococcal Picture
Figure Other Picture
Table All Vaccine Sales Market Share by Applications in 2016
Figure For Adult Picture
Figure For Child Picture
Figure Germany All Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure France All Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure UK All Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Italy All Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Russia All Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Turkey All Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia All Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure UAE All Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Israel All Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Iran All Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa All Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria All Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt All Vaccine Revenue (Value) and Growth Rate (2012-2022)
Figure Algeria All Vaccine Revenue (Value) and Growth Rate (2012-2022)
Table CNBG Basic Information, Manufacturing Base and Competitors
Table CNBG All Vaccine Type and Applications
Table CNBG All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ChengDa Bio Basic Information, Manufacturing Base and Competitors
Table ChengDa Bio All Vaccine Type and Applications
Table ChengDa Bio All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Changsheng Life Basic Information, Manufacturing Base and Competitors
Table Changsheng Life All Vaccine Type and Applications
Table Changsheng Life All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Zhifei Basic Information, Manufacturing Base and Competitors
Table Zhifei All Vaccine Type and Applications
Table Zhifei All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SINOVAC BIOTECH Basic Information, Manufacturing Base and Competitors
Table SINOVAC BIOTECH All Vaccine Type and Applications
Table SINOVAC BIOTECH All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table NuoCheng Bio Basic Information, Manufacturing Base and Competitors
Table NuoCheng Bio All Vaccine Type and Applications
Table NuoCheng Bio All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hualan Bio Basic Information, Manufacturing Base and Competitors
Table Hualan Bio All Vaccine Type and Applications
Table Hualan Bio All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kangtai Basic Information, Manufacturing Base and Competitors
Table Kangtai All Vaccine Type and Applications
Table Kangtai All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SANOFI PASTEUR S.A. Basic Information, Manufacturing Base and Competitors
Table SANOFI PASTEUR S.A. All Vaccine Type and Applications
Table SANOFI PASTEUR S.A. All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis All Vaccine Type and Applications
Table Novartis All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK All Vaccine Type and Applications
Table GSK All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EMEA All Vaccine Sales by Manufacturer (2016-2017)
Figure EMEA All Vaccine Sales Market Share by Manufacturer in 2016
Figure EMEA All Vaccine Sales Market Share by Manufacturer in 2017
Table EMEA All Vaccine Revenue by Manufacturer (2016-2017)
Figure EMEA All Vaccine Revenue Market Share by Manufacturer in 2016
Figure EMEA All Vaccine Revenue Market Share by Manufacturer in 2017
Table EMEA All Vaccine Price by Manufacturer (2016-2017)
Figure EMEA All Vaccine Sales and Growth (2012-2017)
Figure EMEA All Vaccine Revenue and Growth (2012-2017)
Table EMEA All Vaccine Sales by Regions (2012-2017)
Table EMEA All Vaccine Sales Market Share by Regions (2012-2017)
Figure EMEA All Vaccine Sales Market Share by Regions in 2012
Figure EMEA All Vaccine Sales Market Share by Regions in 2016
Table EMEA All Vaccine Revenue by Regions (2012-2017)
Table EMEA All Vaccine Revenue Market Share by Regions (2012-2017)
Figure EMEA All Vaccine Revenue Market Share by Regions in 2012
Figure EMEA All Vaccine Revenue Market Share by Regions in 2016
Figure Europe All Vaccine Sales and Growth (2012-2017)
Figure Middle East All Vaccine Sales and Growth (2012-2017)
Figure Africa All Vaccine Sales and Growth (2012-2017)
Figure Europe All Vaccine Revenue and Growth (2012-2017)
Table Europe All Vaccine Sales by Countries (2012-2017)
Table Europe All Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe All Vaccine Sales Market Share by Countries in 2012
Figure Europe All Vaccine Sales Market Share by Countries in 2016
Table Europe All Vaccine Revenue by Countries (2012-2017)
Table Europe All Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe All Vaccine Revenue Market Share by Countries in 2012
Figure Europe All Vaccine Revenue Market Share by Countries in 2016
Figure Germany All Vaccine Sales and Growth (2012-2017)
Figure France All Vaccine Sales and Growth (2012-2017)
Figure UK All Vaccine Sales and Growth (2012-2017)
Figure Russia All Vaccine Sales and Growth (2012-2017)
Figure Italy All Vaccine Sales and Growth (2012-2017)
Figure Turkey All Vaccine Sales and Growth (2012-2017)
Table Europe All Vaccine Sales by Manufacturer (2016-2017)
Figure Europe All Vaccine Sales Market Share by Manufacturer in 2016
Figure Europe All Vaccine Sales Market Share by Manufacturer in 2017
Table Europe All Vaccine Revenue by Manufacturer (2016-2017)
Figure Europe All Vaccine Revenue Market Share by Manufacturer in 2016
Figure Europe All Vaccine Revenue Market Share by Manufacturer in 2017
Table Europe All Vaccine Sales by Type (2012-2017)
Table Europe All Vaccine Sales Share by Type (2012-2017)
Table Europe All Vaccine Sales by Application (2012-2017)
Table Europe All Vaccine Sales Share by Application (2012-2017)
Figure Middle East All Vaccine Revenue and Growth (2012-2017)
Table Middle East All Vaccine Sales by Countries (2012-2017)
Table Middle East All Vaccine Sales Market Share by Countries (2012-2017)
Figure Middle East All Vaccine Sales Market Share by Countries in 2012
Figure Middle East All Vaccine Sales Market Share by Countries in 2016
Table Middle East All Vaccine Revenue by Countries (2012-2017)
Table Middle East All Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East All Vaccine Revenue Market Share by Countries in 2012
Figure Middle East All Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia All Vaccine Sales and Growth (2012-2017)
Figure Israel All Vaccine Sales and Growth (2012-2017)
Figure UAE All Vaccine Sales and Growth (2012-2017)
Figure Iran All Vaccine Sales and Growth (2012-2017)
Table Middle East All Vaccine Sales by Manufacturer (2016-2017)
Figure Middle East All Vaccine Sales Market Share by Manufacturer in 2016
Figure Middle East All Vaccine Sales Market Share by Manufacturer in 2017
Table Middle East All Vaccine Revenue by Manufacturer (2016-2017)
Figure Middle East All Vaccine Revenue Market Share by Manufacturer in 2016
Figure Middle East All Vaccine Revenue Market Share by Manufacturer in 2017
Table Middle East All Vaccine Sales by Type (2012-2017)
Table Middle East All Vaccine Sales Share by Type (2012-2017)
Table Middle East All Vaccine Sales by Application (2012-2017)
Table Middle East All Vaccine Sales Share by Application (2012-2017)
Figure Africa All Vaccine Revenue and Growth (2012-2017)
Table Africa All Vaccine Sales by Countries (2012-2017)
Table Africa All Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa All Vaccine Sales Market Share by Countries in 2012
Figure Africa All Vaccine Sales Market Share by Countries in 2016
Table Africa All Vaccine Revenue by Countries (2012-2017)
Table Africa All Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa All Vaccine Revenue Market Share by Countries in 2012
Figure Africa All Vaccine Revenue Market Share by Countries in 2016
Figure South Africa All Vaccine Sales and Growth (2012-2017)
Figure Nigeria All Vaccine Sales and Growth (2012-2017)
Figure Egypt All Vaccine Sales and Growth (2012-2017)
Figure Algeria All Vaccine Sales and Growth (2012-2017)
Table Middle East All Vaccine Sales by Manufacturer (2016-2017)
Figure Middle East All Vaccine Sales Market Share by Manufacturer in 2016
Figure Middle East All Vaccine Sales Market Share by Manufacturer in 2017
Table Middle East All Vaccine Revenue by Manufacturer (2016-2017)
Figure Middle East All Vaccine Revenue Market Share by Manufacturer in 2016
Figure Middle East All Vaccine Revenue Market Share by Manufacturer in 2017
Table Middle East All Vaccine Sales by Type (2012-2017)
Table Middle East All Vaccine Sales Share by Type (2012-2017)
Table Middle East All Vaccine Sales by Application (2012-2017)
Table Middle East All Vaccine Sales Share by Application (2012-2017)
Table EMEA All Vaccine Sales by Type (2012-2017)
Table EMEA All Vaccine Sales Share by Type (2012-2017)
Table EMEA All Vaccine Revenue by Type (2012-2017)
Table EMEA All Vaccine Revenue Share by Type (2012-2017)
Figure EMEA Varicella Sales Growth (2012-2017)
Figure EMEA Varicella Price (2012-2017)
Figure EMEA Influenza Sales Growth (2012-2017)
Figure EMEA Influenza Price (2012-2017)
Figure EMEA Polio Sales Growth (2012-2017)
Figure EMEA Polio Price (2012-2017)
Figure EMEA Hepatitis A Sales Growth (2012-2017)
Figure EMEA Hepatitis A Price (2012-2017)
Figure EMEA Rabies Sales Growth (2012-2017)
Figure EMEA Rabies Price (2012-2017)
Figure EMEA BCG Sales Growth (2012-2017)
Figure EMEA BCG Price (2012-2017)
Figure EMEA Hepatitis B Sales Growth (2012-2017)
Figure EMEA Hepatitis B Price (2012-2017)
Figure EMEA Pertussis, Diphtheria, tetanus Sales Growth (2012-2017)
Figure EMEA Pertussis, Diphtheria, tetanus Price (2012-2017)
Figure EMEA Pneumococcal Sales Growth (2012-2017)
Figure EMEA Pneumococcal Price (2012-2017)
Figure EMEA Other Sales Growth (2012-2017)
Figure EMEA Other Price (2012-2017)
Table EMEA All Vaccine Sales by Application (2012-2017)
Table EMEA All Vaccine Sales Share by Application (2012-2017)
Figure EMEA For Adult Sales Growth (2012-2017)
Figure EMEA For Child Sales Growth (2012-2017)
Figure EMEA All Vaccine Sales, Revenue and Growth Rate (2017-2022)
Table EMEA All Vaccine Sales Forecast by Regions (2017-2022)
Table EMEA All Vaccine Market Share Forecast by Regions (2017-2022)
Table Europe All Vaccine Sales Forecast by Regions (2017-2022)
Figure Germany All Vaccine Sales Forecast 2017-2022
Figure France All Vaccine Sales Forecast 2017-2022
Figure UK All Vaccine Sales Forecast 2017-2022
Figure Russia All Vaccine Sales Forecast 2017-2022
Figure Italy All Vaccine Sales Forecast 2017-2022
Figure Turkey All Vaccine Sales Forecast 2017-2022
Table Middle East Sales Forecast by Regions (2017-2022)
Figure Saudi Arabia All Vaccine Sales Forecast 2017-2022
Figure Israel All Vaccine Sales Forecast 2017-2022
Figure UAE All Vaccine Sales Forecast 2017-2022
Figure Iran All Vaccine Sales Forecast 2017-2022
Table Africa Sales Forecast by Regions (2017-2022)
Figure South Africa All Vaccine Sales Forecast 2017-2022
Figure Nigeria All Vaccine Sales Forecast 2017-2022
Figure Egypt All Vaccine Sales Forecast 2017-2022
Figure Algeria All Vaccine Sales Forecast 2017-2022
Table EMEA All Vaccine Sales Forecast by Type (2017-2022)
Table EMEA All Vaccine Market Share Forecast by Type (2017-2022)
Table EMEA All Vaccine Sales Forecast by Application (2017-2022)
Table EMEA All Vaccine Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List
Figure Europe BCG Sales Growth (2012-2017)
Figure Europe BCG Price (2012-2017)
Figure Europe Hepatitis B Sales Growth (2012-2017)
Figure Europe Hepatitis B Price (2012-2017)
Figure Europe Pertussis, Diphtheria, tetanus Sales Growth (2012-2017)
Figure Europe Pertussis, Diphtheria, tetanus Price (2012-2017)
Figure Europe Pneumococcal Sales Growth (2012-2017)
Figure Europe Pneumococcal Price (2012-2017)
Figure Europe Other Sales Growth (2012-2017)
Figure Europe Other Price (2012-2017)